Key result
HNF1A-MODY and GCK-MODY patients had lower flow-mediated dilatation than controls, and HNF1A-MODY patients had higher intima-media thickness.
Why the study?
Do patients with GCK and HNF1A-MODY have increased intima-media thickness and endothelial dysfunction compared to nondiabetic controls?
Cross-Sectional (n=169)
Do patients with GCK and HNF1A-MODY have increased intima-media thickness and endothelial dysfunction compared to nondiabetic controls?
Patients with HNF1A-MODY exhibit early atherosclerotic phenotypes with increased IMT, and both GCK and HNF1A-MODY patients show evidence of endothelial dysfunction compared to healthy controls.
Answers are grounded in this paper and cite their sources.
Endothelial dysfunction in GCK- and HNF1A-MODY may signal early vascular risk; hypothesis-generating and leaves open need for longitudinal outcome studies.
OBJECTIVE: Mutations in the glucokinase (GCK) gene, along with hepatocyte nuclear factor 1A (HNF1A) gene mutations, are the most frequent cause of maturity-onset diabetes of the young (MODY). GCK-MODY patients are typically characterized by a moderate fasting hyperglycemia; however, little is known about atherosclerosis and intermediate-related phenotypes in these subjects. DESIGN: To examine carotid artery intima-media thickness (IMT) and endothelial function assessed by brachial artery flow-mediated dilatation (FMD) in GCK gene mutations carriers and HNF1A-MODY. METHODS: A total of 64 subjects with GCK gene mutations, and 52 HNF1A gene mutation carriers as well as 53 nondiabetic controls were examined. IMT and FMD were assessed by ultrasonography. Appropriate statistical tests were performed to assess differences between the groups, and multivariate linear regression was done for the association with IMT and FMD. RESULTS: The clinical characteristics of all groups were similar with the mean age at examination of 35.1, 41.1, and 39.5 years for GCK, HNF1A and the control group respectively. The highest mean IMT value was in the HNF1A-MODY group: 7.0±1.4 mm, whereas it reached 6.3±1.4 mm in GCK mutation carriers and 6.3±1.3 mm in controls (P=0.008). After adjustment for possible clinical and biochemical cofounders, IMT remained higher in HNF1A-MODY patients as compared with GCK-MODY patients (P=0.02) and controls (P=0.0003). FMD was significantly lower in HNF1A (9.9±4.6%) and GCK-MODY (11.1±4.6%) patients in comparison with controls (13.9±4.7%; P=0.0001). After adjustment, FMD remained lower in HNF1A-MODY (P=0.0005) and GCK-MODY patients (P=0.01) as compared with controls. CONCLUSIONS: Both examined MODY groups demonstrated evidence of endothelial dysfunction. In addition, HNF1-MODY patients seem to be more prone to an early atherosclerotic phenotype.
No takes yet. Share an insight, caveat, or question.
Szopa et al. (2014) conducted a cross-sectional in Maturity-onset diabetes of the young (MODY) (n=169). GCK and HNF1A gene mutations vs. Nondiabetic controls was evaluated on Carotid artery intima-media thickness (IMT) and endothelial function assessed by brachial artery flow-mediated dilatation (FMD) (p=0.008). HNF1A-MODY and GCK-MODY patients had lower flow-mediated dilatation than controls, and HNF1A-MODY patients had higher intima-media thickness.
Synapse has enriched 10 related papers. Consider them for comparative context: